需要更多措施来补充现有的脊髓性肌萎缩症治疗方法。 - Suppr

Suppr

超能文献

More is needed to complement the available therapies of spinal muscular atrophy.

作者信息

Singh Ravindra N

机构信息

Department of Biomedical Science, Iowa State University, Ames, IA 50011, USA.

出版信息

Future Med Chem. 2019 Nov;11(22):2873-2876. doi: 10.4155/fmc-2019-0239. Epub 2019 Oct 31.

DOI:10.4155/fmc-2019-0239

PMID:31668092

Abstract

摘要

相似文献

More is needed to complement the available therapies of spinal muscular atrophy.需要更多措施来补充现有的脊髓性肌萎缩症治疗方法。

Future Med Chem. 2019 Nov;11(22):2873-2876. doi: 10.4155/fmc-2019-0239. Epub 2019 Oct 31.

Nusinersen in the Treatment of Spinal Muscular Atrophy.诺西那生钠治疗脊髓性肌萎缩症

Methods Mol Biol. 2018;1828:69-76. doi: 10.1007/978-1-4939-8651-4_4.

How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy.国际脊髓性肌萎缩症协作组1（ISS-N1）的发现是如何促成脊髓性肌萎缩症的首个医学疗法的。

Gene Ther. 2017 Sep;24(9):520-526. doi: 10.1038/gt.2017.34. Epub 2017 May 9.

High Concentration of an ISS-N1-Targeting Antisense Oligonucleotide Causes Massive Perturbation of the Transcriptome.高浓度靶向 ISS-N1 的反义寡核苷酸导致转录组的大规模紊乱。

Int J Mol Sci. 2021 Aug 4;22(16):8378. doi: 10.3390/ijms22168378.

Recent Advances and Clinical Applications of Exon Inclusion for Spinal Muscular Atrophy.脊髓性肌萎缩症外显子包含的最新进展及临床应用

Methods Mol Biol. 2018;1828:57-68. doi: 10.1007/978-1-4939-8651-4_3.

Zolgensma - one-time gene therapy for spinal muscular atrophy.佐尔根斯马——用于脊髓性肌萎缩症的一次性基因疗法。

Med Lett Drugs Ther. 2019 Jul 29;61(1577):113-114.

Curing SMA: Are we there yet?治愈脊髓性肌萎缩症：我们做到了吗？

Gene Ther. 2023 Feb;30(1-2):8-17. doi: 10.1038/s41434-022-00349-y. Epub 2022 May 26.

Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy.依库珠单抗治疗脊髓性肌萎缩症

Yonsei Med J. 2020 Apr;61(4):273-283. doi: 10.3349/ymj.2020.61.4.273.

Moving towards treatments for spinal muscular atrophy: hopes and limits.迈向脊髓性肌萎缩症的治疗：希望与局限

Expert Opin Emerg Drugs. 2015 Sep;20(3):353-6. doi: 10.1517/14728214.2015.1041375. Epub 2015 Jul 3.

Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy Therapy.脊髓性肌萎缩症治疗中当前药物和分子的概述。

Drugs. 2018 Mar;78(3):293-305. doi: 10.1007/s40265-018-0868-8.

引用本文的文献

Safety and Efficacy of Nusinersen and Risdiplam for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.诺西那生钠和利司扑兰治疗脊髓性肌萎缩症的安全性和有效性：一项随机对照试验的系统评价和荟萃分析

Brain Sci. 2023 Oct 7;13(10):1419. doi: 10.3390/brainsci13101419.

Diverse targets of SMN2-directed splicing-modulating small molecule therapeutics for spinal muscular atrophy.针对脊髓性肌萎缩症的 SMN2 靶向剪接调节小分子治疗的多样化靶点。

Nucleic Acids Res. 2023 Jul 7;51(12):5948-5980. doi: 10.1093/nar/gkad259.

Structural Context of a Critical Exon of Spinal Muscular Atrophy Gene.脊髓性肌萎缩症基因关键外显子的结构背景

Front Mol Biosci. 2022 Jul 1;9:928581. doi: 10.3389/fmolb.2022.928581. eCollection 2022.

Heat increases full-length SMN splicing: promise for splice-augmenting therapies for SMA.高温增加全长 SMN 剪接：SMA 剪接增强治疗的希望。

Hum Genet. 2022 Feb;141(2):239-256. doi: 10.1007/s00439-021-02408-7. Epub 2022 Jan 28.

High Concentration of an ISS-N1-Targeting Antisense Oligonucleotide Causes Massive Perturbation of the Transcriptome.高浓度靶向 ISS-N1 的反义寡核苷酸导致转录组的大规模紊乱。

Int J Mol Sci. 2021 Aug 4;22(16):8378. doi: 10.3390/ijms22168378.

Case Report: Whole-Exome Sequencing With MLPA Revealed Variants in Two Genes in a Patient With Combined Manifestations of Spinal Muscular Atrophy and Duchenne Muscular Dystrophy.病例报告：全外显子测序联合多重连接探针扩增技术揭示了一名患有脊髓性肌萎缩症和杜氏肌营养不良症联合表现患者的两个基因中的变异。

Front Genet. 2021 Mar 10;12:605611. doi: 10.3389/fgene.2021.605611. eCollection 2021.

Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes.脊髓性肌萎缩症：广泛的疾病谱和性别特异性表型。

Biochim Biophys Acta Mol Basis Dis. 2021 Apr 1;1867(4):166063. doi: 10.1016/j.bbadis.2020.166063. Epub 2021 Jan 5.

U2AF65-Dependent SF3B1 Function in SMN Alternative Splicing.U2AF65 依赖性 SF3B1 功能在 SMN 可变剪接中的作用。

Cells. 2020 Dec 9;9(12):2647. doi: 10.3390/cells9122647.

The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy.首款用于治疗脊髓性肌萎缩症的口服小分子药物。

Neurosci Insights. 2020 Nov 23;15:2633105520973985. doi: 10.1177/2633105520973985. eCollection 2020.

RNA in spinal muscular atrophy: therapeutic implications of targeting.脊髓性肌萎缩症中的 RNA：靶向治疗的意义。

Expert Opin Ther Targets. 2020 Aug;24(8):731-743. doi: 10.1080/14728222.2020.1783241. Epub 2020 Jun 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验